{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:09:22Z","timestamp":1786990162472,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.htct.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T02:12:24Z","timestamp":1670206344000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-5495","authenticated-orcid":false,"given":"Kaira Mara Cordeiro de","family":"Albuquerque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7530-6050","authenticated-orcid":false,"given":"Caroline Brand\u00e3o","family":"Joventino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia Correia","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-0969","authenticated-orcid":false,"given":"Hermano Alexandre Lima","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Andrade","family":"Gurgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8630-3739","authenticated-orcid":false,"given":"Deivide de Sousa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1367-6782","authenticated-orcid":false,"given":"Carlos Ewerton Maia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2022.11.002_bib0001","series-title":"Estimativa 2016: incid\u00eancia de c\u00e2ncer no Brasil","year":"2015"},{"key":"10.1016\/j.htct.2022.11.002_bib0002","series-title":"Leukemia - Acute Myeloid - AML: Starisrics","year":"2021"},{"key":"10.1016\/j.htct.2022.11.002_bib0003","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12032-018-1179-3","article-title":"Overall survival of Brazilian acute myeloid leukemia patients according to the European Leukemia Net prognostic scoring system: a cross-sectional study","volume":"35","author":"Datoguia","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.htct.2022.11.002_bib0004","first-page":"21","volume":"37","author":"Padilha","year":"2015"},{"key":"10.1016\/j.htct.2022.11.002_bib0005","series-title":"Tratado de hematologia","author":"Zago","year":"2013"},{"key":"10.1016\/j.htct.2022.11.002_bib0006","doi-asserted-by":"crossref","first-page":"72044","DOI":"10.18632\/oncotarget.12495","article-title":"Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: a national population-based cohort study of Danish intensive chemotherapy patients","volume":"7","author":"\u00d8stg\u00e5rd","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.htct.2022.11.002_bib0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/s1679-45082011ao1853","article-title":"Acute myeloid leucemia: update in diagnosis and treatment in Brazil","volume":"9","author":"Helman","year":"2011","journal-title":"Einstein"},{"key":"10.1016\/j.htct.2022.11.002_bib0008","first-page":"33","article-title":"Leucemia miel\u00f3ide aguda do adulto: an\u00e1lise retrospectiva de 99 casos","volume":"17","author":"Fagundes","year":"1995","journal-title":"Bol. Soc. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.htct.2022.11.002_bib0009","series-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.htct.2022.11.002_bib0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.htct.2022.11.002_bib0011","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.htct.2022.11.002_bib0012","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Reporto of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.htct.2022.11.002_bib0013","series-title":"DSM-IV: Manual de Diagn\u00f3stico e Estat\u00edstica das Perturba\u00e7\u00f5es Mentais","year":"1994"},{"key":"10.1016\/j.htct.2022.11.002_bib0014","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1176\/ajp.131.10.1121","article-title":"The CAGE questionnaire: validation of new alcoholism screning instrument","volume":"131","author":"Mayfield","year":"1974","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.htct.2022.11.002_bib0015","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2007-07-099978","article-title":"Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of FrenchBelgian-Swiss and PETHEMA results","volume":"111","author":"Ad\u00e8s","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.htct.2022.11.002_bib0016","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/ajh.25214","article-title":"Acute myeloid leukemia: 2019 update on risk stratification and management","volume":"93","author":"Estey","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.htct.2022.11.002_bib0017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/asheducation-2009.1.385","article-title":"Independent prognostic factors for AML outcome","author":"Grimwade","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.htct.2022.11.002_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOH.0b013e3283257adb","article-title":"Impact of new prognostic markers in treatment decisions in acute myeloid leukemia","volume":"16","author":"Schlenk","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.htct.2022.11.002_bib0019","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/s1679-45082011ao2041","article-title":"Molecular and cytogenetic abnormalities in acute myeloid leukemia: review and case studies","volume":"9","author":"Velloso","year":"2011","journal-title":"Einstein"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137922014638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137922014638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:37:41Z","timestamp":1762868261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137922014638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2531137922014638"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2022.11.002","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}